Gastrointestinal Stromal Tumors of the Small Intestine: Progress in Diagnosis and Treatment Research

References

• Lai ECH, Lau SHY, Lau WY. Current management of gastrointestinal stromal tumors-a comprehensive review. Int J Surg. 2012;10(7):334–340. doi:10.1016/j.ijsu.2012.05.00722633986
   PubMed Web of Science ®Google Scholar
• Zhang FB, Shi HC, Shu YS, et al. Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors. World J Gastroenterol. 2015;21(18):5630–5634. doi:10.3748/wjg.v21.i18.563025987788
   PubMed Web of Science ®Google Scholar
• Lott S, Schmieder M, Mayer B, et al. Gastrointestinal stromal tumors of the esophagus: evaluation of a pooled case series regarding clinicopathological features and clinical outcome. Am J Cancer Res. 2015;5(1):333.25628942
   PubMed Web of Science ®Google Scholar
• Nakano A, Nakamura M, Watanabe O, et al. Endoscopic Characteristics, Risk Grade, and Prognostic Prediction in Gastrointestinal Stromal Tumors of the Small Bowel. Digestion. 2017;95(2):122–131. doi:10.1159/00045472828161705
   PubMed Web of Science ®Google Scholar
• Shinya T, Inai R, Tanaka T, et al. Small bowel neoplasms: enhancement patterns and differentiation using post-contrast multiphasic multidetector CT. Abdom Radiol (NY). 2017;42(3):794–801. doi:10.1007/s00261-016-0945-y27783113
   PubMed Web of Science ®Google Scholar
• Chung CS, Tai CM, Huang TY, et al. Small bowel tumors: a Dig Endosc society of Taiwan (DEST) multicenter enteroscopy-based epidemiologic study. J Formos Med Assoc. 2018;117(8):705–710. doi:10.1016/j.jfma.201709.00328988888
   PubMed Web of Science ®Google Scholar
• Levy AD, Remotti HE, Thompson WM, et al. From the archives of the AFIP: gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003;23(2):283–304. doi:10.1148/rg.24203518712640147
   PubMed Web of Science ®Google Scholar
• Lupescu IG, Grasu M, Boros M, et al. Gastrointestinal stromal tumors: retrospective analysis of the computer-tomographic aspects. J Gastrointestin Liver Dis. 2007;16(2):147. doi:10.1111/j.1440-1746.2006.04663.x17592560
   PubMed Web of Science ®Google Scholar
• Xing G, Wang S, Sun YM, et al. Small bowel stromal tumors: different clinicopathologic and computed tomography features in various anatomic sites. PLoS One. 2015;10(12):e0144277. doi:10.1371/journal.pone.014427726646242
   PubMed Web of Science ®Google Scholar
• Yacob M, Inian S, Sudhakar CB. Gastrointestinal stromal tumours: review of 150 cases from a single centre. Indian J Surg. 2015;77(2):505–510. doi:10.1007/s12262-013-0899-z26730054
   PubMedGoogle Scholar
• Cameron S, Beham A, Schildhaus HU. Current standard and future perspectives in the treatment of gastrointestinal stromal tumors. Digestion. 2017;95(4):262–268. doi:10.1159/00045583528384644
   PubMed Web of Science ®Google Scholar
• Scherübl H, Faiss S, Knoefel WT, et al. Management of early asymptomatic gastrointestinal stromal tumors of the stomach. World J Gastrointest Endosc. 2014;6(7):266. doi:10.4253/wjge.v6.i7.26625031785
   PubMedGoogle Scholar
• Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002;38:S39–S51. doi:10.1016/s0959-8049(02)80602-5
   PubMed Web of Science ®Google Scholar
• Morrison JE, Hodgdon IA. Laparoscopic management of obstructing small bowel GIST tumor. JSLS. 2013;17(4):645. doi:10.4293/108680813X1379452266744524398210
   PubMed Web of Science ®Google Scholar
• Martis JJ, Rajeshwara KV, Murulya KS, et al. A rare cause of jejunojejunal intussusception in an adult. Indian J Surg. 2013;75(1):18–20. doi:10.1007/s12262-011-0295-524426499
   PubMedGoogle Scholar
• Rodrigues RV, da Silva JP, Pereira AD. Small bowel Gastrointestinal Stromal Tumor (GIST) presenting with liver abscesses. J Gastrointest Cancer. 2016;47(4):497–501. doi:10.1007/s12029-015-9793-126680222
   PubMedGoogle Scholar
• Yamamoto H, Kojima A, Miyasaka Y, et al. Prognostic impact of blood vessel invasion in gastrointestinal stromal tumor of the stomach. Hum Pathol. 2010;41(10):1422–1430. doi:10.1016/j.humpath.2010.02.01320573370
   PubMed Web of Science ®Google Scholar
• Nishida T, Kawai N, Yamaguchi S, et al. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc. 2013;25(5):479–489. doi:10.1111/den.1214923902569
   PubMed Web of Science ®Google Scholar
• Zhang L, Smyrk TC, Young WF Jr, et al. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol. 2010;34(1):53. doi:10.1097/PAS.0b013e3181c20f4f19935059
   PubMed Web of Science ®Google Scholar
• Miettinen M, Killian JK, Wang ZF, et al. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol. 2013;37(2):234. doi:10.1097/PAS.0b013e318267117823282968
   PubMed Web of Science ®Google Scholar
• Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10(2):81–89. doi:10.1053/hupa.2002.12354512075401
   PubMed Web of Science ®Google Scholar
• Na HK, Lee JH, Park YS, et al. Yields and utility of endoscopic ultrasonography-guided 19-gauge trucut biopsy versus 22-gauge fine needle aspiration for diagnosing gastric subepithelial tumors. Clin Endosc. 2015;48(2):152. doi:10.5946/ce.2015.48.2.15225844344
   PubMedGoogle Scholar
• Cho JW, Korean ESD Study Group. Current guidelines in the management of upper gastrointestinal subepithelial tumors. Clin Endosc. 2016;49(3):235. doi:10.5946/ce.2015.09626898512
   PubMedGoogle Scholar
• Nishida T, Blay JY, Hirota S, et al. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19(1):3–14. doi:10.1007/s10120-015-0526-826276366
   PubMed Web of Science ®Google Scholar
• Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008;32(2):210–218. doi:10.1097/PAS.0b013e3181238cec18223323
   PubMed Web of Science ®Google Scholar
• Lopes LF, West RB, Bacchi LM, et al. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohisto M M. 2010;18(4):333–337. doi:10.1097/PAI.0b013e3181d27ec8
   Web of Science ®Google Scholar
• Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33(9):1401–1408. doi:10.1097/PAS.0b013e3181a90e1a19606013
   PubMed Web of Science ®Google Scholar
• Rubin BP, Blanke CD, Demetri GD, et al. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol Lab Med. 2010;134(2):165–170. doi:10.1043/1543-2165-134.2.16520121601
   PubMed Web of Science ®Google Scholar
• Ávila SA, Peñaloza J, González F, et al. Dysphagia, melanosis, gastrointestinal stromal tumors and a germinal mutation of the KIT gene in an argentine family. Acta Gastroenterol Latinoam. 2014;44(1):9–15.24847623
   PubMedGoogle Scholar
• Taira N, Ohsumi S, Takabatake D, et al. Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer. Jpn J Clin Oncol. 2008;38(6):419–425. doi:10.1093/jjco/hyn04018502779
   PubMed Web of Science ®Google Scholar
• Tateishi U, Hasegawa T, Satake M, et al. Gastrointestinal stromal tumor: correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr. 2003;27(5):792–798. doi:10.1097/00004728-200309000-0001814501372
   PubMed Web of Science ®Google Scholar
• Paulsen SR, Huprich JE, Fletcher JG, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics. 2006;26(3):641–657. doi:10.1148/rg.26305516216702444
   PubMed Web of Science ®Google Scholar
• Verde F, Hruban RH, Fishman EK. Small bowel gastrointestinal stromal tumors: multidetector computed tomography enhancement pattern and risk of progression. J Comput Assist Tomogr. 2017;41(3):407–411. doi:10.1097/RCT.000000000000052627824674
   PubMed Web of Science ®Google Scholar
• Vasconcelos RN, Dolan SG, Barlow JM, et al. Impact of CT enterography on the diagnosis of small bowel gastrointestinal stromal tumors. Abdom Radiol. 2017;42(5):1365–1373. doi:10.1007/s00261-016-1033-z
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Shimada M, Kurita N, et al. The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors. Surg Today. 2013;43(10):1162–1167. doi:10.1007/s00595-012-0411-623143169
   PubMed Web of Science ®Google Scholar
• Vernuccio F, Taibbi A, Picone D, et al. Imaging of gastrointestinal stromal tumors: from diagnosis to evaluation of therapeutic response. Anticancer Res. 2016;36(6):2639–2648.27272772
   PubMed Web of Science ®Google Scholar
• Gayed I, Vu T, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004;45(1):17–21.14734662
   PubMed Web of Science ®Google Scholar
• Jiang ZX, Zhang SJ, Peng WJ, et al. Rectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlation. World J Gastroenterol. 2013;19(20):3108. doi:10.3748/wjg.v19.i20.310823716991
   PubMed Web of Science ®Google Scholar
• Yu MH, Lee JM, Baek JH, et al. MRI features of gastrointestinal stromal tumors. Am J Roentgenol. 2014;203(5):980–991. doi:10.2214/AJR.13.1166725341135
   PubMed Web of Science ®Google Scholar
• Tasaki A, Asatani MO, Umezu H, et al. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density. Abdom Imaging. 2015;40(6):1742–1752. doi:10.1007/s00261-014-0324-525526683
   PubMedGoogle Scholar
• Sato K, Yuasa N, Fujita M, et al. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol. 2014;210(4):368.e1-368.e8. doi:10.1016/j.ajog.2013.12.028
   PubMed Web of Science ®Google Scholar
• Chen YT, Sun HL, Luo JH, et al. Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding. World J Gastroenterol. 2014;20(47):17955. doi:10.3748/wjg.v20.i47.1795525548494
   PubMed Web of Science ®Google Scholar
• Hedenström P, Nilsson B, Demir A, et al. Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies. World J Gastroenterol. 2017;23(32):5925. doi:10.3748/wjg.v23.i32.592528932084
   PubMed Web of Science ®Google Scholar
• Sekine M, Imaoka H, Mizuno N, et al. Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Dig Endosc. 2015;27(1):44–52. doi:10.1111/den.1233325059428
   PubMed Web of Science ®Google Scholar
• Cantor MJ, Davila RE, Faigel DO. Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. Gastrointest Endosc. 2006;64(1):29–34. doi:10.1016/j.gie.2006.02.02716813799
   PubMed Web of Science ®Google Scholar
• Hwang JH, Saunders MD, Rulyak SJ, et al. A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. Gastrointest Endosc. 2005;62(2):202–208. doi:10.1016/s0016-5107(05)01567-116046979
   PubMed Web of Science ®Google Scholar
• Gress F, Schmitt C, Savides T, et al. Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses. Gastrointest Endosc. 2001;53(1):71–76. doi:10.1067/mge.2001.11138411154492
   PubMed Web of Science ®Google Scholar
• Hwang JH, Rulyak SD, Kimmey MB, American Gastroenterological Association Institute. American gastroenterological association institute technical review on the management of gastric subepithelial masses. Gastroenterology. 2006;130(7):2217–2228. doi:10.1053/j.gastro.2006.04.03316762644
   PubMed Web of Science ®Google Scholar
• Fernández-Esparrach G, Sendino O, Solé M, et al. Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy. 2010;42(04):292–299. doi:10.1055/s-0029-124407420354939
   PubMedGoogle Scholar
• Lee JH, Cho CJ, Park YS, et al. EUS-guided 22-gauge fine needle biopsy for the diagnosis of gastric subepithelial tumors larger than 2 cm. Scand J Gastroenterol. 2016;51(4):486–493. doi:10.3109/00365521.2015.105209526061486
   PubMed Web of Science ®Google Scholar
• Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosco. 2005;61(3):467–472. doi:10.1016/s0016-5107(04)02802-0
   PubMed Web of Science ®Google Scholar
• Varadarajulu S, Fraig M, Schmulewitz N, et al. Comparison of EUS-guided 19-gauge Trucut needle biopsy with EUS-guided fine-needle aspiration. Endoscopy. 2004;36(05):397–401. doi:10.1055/s-2004-81431615100946
   PubMedGoogle Scholar
• Vadakara J, von Mehren M. Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies. Hematol Oncol Clin. 2013;27(5):905–920. doi:10.1016/j.hoc.2013.07.007
   PubMed Web of Science ®Google Scholar
• Wada N, Kurokawa Y, Takahashi T, et al. Detecting secondary C-KIT mutations in the peripheral blood of patients with imatinib-resistant gastrointestinal stromal tumor. Oncology. 2016;90(2):112–117. doi:10.1159/00044294826779618
   PubMed Web of Science ®Google Scholar
• Feng F, Tian Y, Liu Z, et al. Clinicopathological features and prognosis of colonic gastrointestinal stromal tumors: evaluation of a pooled case series. Oncotarget. 2016;7(26):40735. doi:10.18632/oncotarget.919627166191
   PubMedGoogle Scholar
• Brohl AS, Demicco EG, Mourtzikos K, et al. Response to sunitinib of a gastrointestinal stromal tumor with a rare exon 12 PDGFRA mutation. Clin Sarcoma Res. 2015;5(1):21. doi:10.1186/s13569-015-0036-926396737
   PubMedGoogle Scholar
• Boye K, Berner JM, Hompland I, et al. Genotype and risk of tumour rupture in gastrointestinal stromal tumour. Br J Surg. 2018;105(2):e169–e175. doi:10.1002/bjs.1074329341147
   PubMed Web of Science ®Google Scholar
• Zheng S, Huang K, Pan Y, et al. KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance. Gastric Cancer. 2015;18(4):796–802. doi:10.1007/s10120-014-0414-725182956
   PubMed Web of Science ®Google Scholar
• Urbini M, Indio V, Tarantino G, et al. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST. Genes Chromosomes Cancer. 2019;58(9):636–642. doi:10.1002/gcc.2275330887595
   PubMed Web of Science ®Google Scholar
• Lasota J, Kowalik A, Felisiak-Golabek A, et al. New mechanisms of mTOR pathway activation in KIT-mutant malignant GISTs. Appl Immunohisto M M. 2019;27(1):54–58. doi:10.1097/PAI.0000000000000541
   Web of Science ®Google Scholar
• Ihn K, Hyung WJ, Kim HI, et al. Treatment results of small intestinal gastrointestinal stromal tumors less than 10 cm in diameter: a comparison between laparoscopy and open surgery. J Gastric Cancer. 2012;12(4):243–248. doi:10.5230/jgc.2012.12.4.24323346497
   PubMedGoogle Scholar
• Liao CH, Yeh CN, Wang SY, et al. Surgical option for intestinal gastrointestinal stromal tumors–Perioperative and oncological outcomes of laparoscopic surgery. Anticancer Res. 2015;35(2):1033–1040.25667491
   PubMed Web of Science ®Google Scholar
• Tabrizian P, Nguyen SQ, Divino CM. Laparoscopic management and longterm outcomes of gastrointestinal stromal tumors. J Am Coll Surg. 2009;208(1):80–86. doi:10.1016/j.jamcollsurg.2008.08.02819228508
   PubMed Web of Science ®Google Scholar
• Chen K, Zhang B, Liang YL, et al. Laparoscopic versus open resection of small bowel gastrointestinal stromal tumors: systematic review and meta-analysis. Chin Med J Peking. 2017;130(13):1595. doi:10.4103/0366-6999.208249
   PubMed Web of Science ®Google Scholar
• Tsui DK, Tang CN, Ha JP, et al. Laparoscopic approach for small bowel tumors. Surg Laparosc Endosc Percutan Tech. 2008;18(6):556–560. doi:10.1097/SLE.0b013e3181889d2519098659
   PubMed Web of Science ®Google Scholar
• Koh YX, Chok AY, Zheng HL, et al. A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol. 2013;20(11):3549–3560. doi:10.1245/s10434-013-3051-123793362
   PubMed Web of Science ®Google Scholar
• Katz SC, DeMatteo RP. Gastrointestinal stromal tumors and leiomyosarcomas. J Surgical Oncol. 2008;97(4):350–359. doi:10.1002/jso.20970
   PubMed Web of Science ®Google Scholar
• Koo DH, Ryu MH, Kim KM, et al. Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer Res Treat. 2016;48(4):1155. doi:10.4143/crt.2016.18727384163
   PubMed Web of Science ®Google Scholar
• Liao CH, Liu YY, Chen CC, et al. Single-incision laparoscopic-assisted surgery for small bowel obstruction. J Laparoendosco Adv A. 2012;22(10):957–961. doi:10.1089/lap.2012.0193
   PubMed Web of Science ®Google Scholar
• Duepree HJ, Senagore AJ, Delaney CP, et al. Does means of access affect the incidence of small bowel obstruction and ventral hernia after bowel resection?: laparoscopy versus laparotomy. J Am Coll Surg. 2003;197(2):177–181. doi:10.1016/S1072-7515(03)00232-112892794
   PubMed Web of Science ®Google Scholar
• Chen YH, Liu KH, Yeh CN, et al. Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosco Adv A. 2012;22(8):758–763. doi:10.1089/lap.2012.0115
   PubMed Web of Science ®Google Scholar
• Corless CL, Ballman KV, Antonescu CR, et al. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014;32(15):1563. doi:10.1200/JCO.2013.51.204624638003
   PubMed Web of Science ®Google Scholar
• Mulet-Margalef N, Garcia-del-Muro X. Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives. Onco Targets Ther. 2016;9:7573. doi:10.2147/OTT.S10138528008275
   PubMed Web of Science ®Google Scholar
• Guller U, Tarantino I, Cerny T, et al. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis. Gastric Cancer. 2017;20(1):49–60. doi:10.1007/s10120-015-0571-326649434
   PubMed Web of Science ®Google Scholar
• Ramaswamy A, Bal M, Swami R, et al. Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib. Ann Transl Med. 2017;5(6). doi:10.21037/atm.2017.03.31
   PubMed Web of Science ®Google Scholar
• Heinrich MC, von Mehren M, Demetri GD, et al. Phase 2 study of ponatinib in patients (pts) with advanced gastrointestinal stromal tumors (GIST) after failure of tyrosine kinase inhibitor (TKI) therapy: early results. Ann Oncol. 2014;25:iv496. doi:10.1093/annonc/mdu354.6
   Google Scholar
• DeMatteo RP, Ballman KV, Antonescu CR, et al. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg. 2013;258(3):422. doi:10.1097/SLA.0b013e3182a15eb723860199
   PubMed Web of Science ®Google Scholar
• Singh AS, Chmielowski B, Hecht JR, et al. A randomized phase 2 study of nivolumab monotherapy versus nivolumab combined with ipilimumab in patients with metastatic or unresectable gastrointestinal stromal tumor (GIST). J Clin Oncol. 2018;55.
   Google Scholar
• Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol. 2009;99(1):42–47. doi:10.1002/jso.2116018942073
   PubMed Web of Science ®Google Scholar
• Fiore M, Palassini E, Fumagalli E, et al. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). EJSO. 2009;35(7):0–745. doi:10.1016/j.ejso.2008.11.005
   Web of Science ®Google Scholar
• Bednarski BK, Araujo DM, Yi M, et al. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Ann Surg Oncol. 2014;21(8):2499–2505. doi:10.1245/s10434-014-3632-724639192
   PubMed Web of Science ®Google Scholar
• Tirumani SH, Shinagare AB, Jagannathan JP, et al. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol. 2014;40(4):420–428. doi:10.1016/j.ejso.2013.10.02124238762
   PubMed Web of Science ®Google Scholar
• Demetri GD, Von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Ne. 2010;8(Suppl_2):S-1-S-41. doi:10.6004/jnccn.2010.0116
   Google Scholar
• Kang G, Kang Y, Kim KH, et al. Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases. Histopathology. 2017;71(5):805–812. doi:10.1111/his.1329228644569
   PubMed Web of Science ®Google Scholar
• Blanke CD, Rankin C, Demetri GD, et al. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the KIT receptor tyrosine kinase: S0033. J Clin Oncol. 2008;26(4):626–632. doi:10.1200/JCO.2007.13.445218235122
   PubMed Web of Science ®Google Scholar
• Raut CP, Posner M, Desai J, et al. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol. 2006;24(15):2325–2331. doi:10.1200/JCO.2005.05.343916710031
   PubMed Web of Science ®Google Scholar
• Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019;10(1):144. doi:10.21037/jgo.2018.08.2030788170
   PubMed Web of Science ®Google Scholar
• Günter E, Lingenfelser T, Eitelbach F, et al. EUS-guided ethanol injection for treatment of a GI stromal tumor. Gastrointest Endosc. 2003;57(1):113–115. doi:10.1067/mge.2003.3912518147
   PubMed Web of Science ®Google Scholar
• Casali PG, Abecassis N, Bauer S, et al. Gastrointestinal stromal tumours: ESMO–EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Supplement_4):iv68–iv78. doi:10.1093/annonc/mdy32029846513
   PubMedGoogle Scholar
• Hølmebakk T, Bjerkehagen B, Boye K, et al. Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine. Br J Surg. 2016;103(6):684–691. doi:10.1002/bjs.1010426988241
   PubMed Web of Science ®Google Scholar
• Giuliano K, Ejaz A, Reames BN, et al. Comparing the long‐term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: an analysis of the National Cancer Database. J Surg Oncol. 2018;118(3):486–492. doi:10.1002/jso.2517230129672
   PubMed Web of Science ®Google Scholar
• Giuliano K, Nagarajan N, Canner J, et al. Gastric and small intestine gastrointestinal stromal tumors: do outcomes differ? J Surg Oncol. 2017;115(3):351–357. doi:10.1002/jso.2451427885685
   PubMed Web of Science ®Google Scholar
• Zhang S, Zheng C, Chen Y, et al. Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: a retrospective study in China. Int J Surg. 2017;43:145–154. doi:10.1016/j.ijsu.2017.05.07628583893
   PubMed Web of Science ®Google Scholar
• Tabrizian P, Sweeney RE, Uhr JH, et al. Laparoscopic resection of gastric and small bowel gastrointestinal stromal tumors: 10-year experience at a single center. J Am Coll Surg. 2014;218(3):367–373. doi:10.1016/j.jamcollsurg.2013.11.02924559952
   PubMed Web of Science ®Google Scholar
• Joensuu H, Eriksson M, Hall KS, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265–1272. doi:10.1001/jama.2012.34722453568
   PubMed Web of Science ®Google Scholar
• Joensuu H, Martin-Broto J, Nishida T, et al. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery. Eur J Cancer. 2015;51(12):1611–1617. doi:10.1016/j.ejca.2015.05.00926022432
   PubMed Web of Science ®Google Scholar
• Benjamin RS, Casali PG. Adjuvant imatinib for GI stromal tumors: when and for how long? J Clin Oncol. 2015;34(3):215–218. doi:10.1200/JCO.2015.64.010226644523
   PubMed Web of Science ®Google Scholar
• Rutkowski P, Gronchi A, Hohenberger P, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937–2943. doi:10.1245/s10434-013-3013-723760587
   PubMed Web of Science ®Google Scholar
• Raut CP, Espat NJ, Maki RG, et al. Extended treatment with adjuvant imatinib (IM) for patients (pts) with high-risk primary gastrointestinal stromal tumor (GIST): the PERSIST-5 study. J Clin Oncol. 2017;35(15_suppl):11009. doi:10.1200/JCO.2017.35.15_suppl.11009
   Google Scholar
• Wada N, Kurokawa Y, Nishida T, et al. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study. J Surg Oncol. 2014;109(2):67–70. doi:10.1002/jso.2347124155204
   PubMed Web of Science ®Google Scholar
• Wan P, Li C, Yan M, et al. Laparoscopy-assisted versus open surgery for gastrointestinal stromal tumors of jejunum and ileum: perioperative outcomes and long-term follow-up experience. Am Surg. 2012;78(12):1399–1404. doi:10.1177/155335061143272323265132
   PubMed Web of Science ®Google Scholar
• Sandvik OM, Søreide K, Gudlaugsson E, et al. Surgery for gastrointestinal stromal tumors (GISTs) of the stomach and small bowel: short-and long-term outcomes over three decades. World J Surg. 2015;39(2):446–452. doi:10.1007/s00268-014-2824-425315092
   PubMed Web of Science ®Google Scholar
• Güller U, Tarantino I, Cerny T, et al. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC Cancer. 2015;15(1):557. doi:10.1186/s12885-015-1554-926223313
   PubMedGoogle Scholar
• Kukar M, Kapil A, Papenfuss W, et al. Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis. J Surg Oncol. 2015;111(6):696–701. doi:10.1002/jso.2387325560251
   PubMed Web of Science ®Google Scholar
• Ma GL, Murphy JD, Martinez ME, et al. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Prev Biomarkers. 2015;24(1):298–302. doi:10.1158/1055-9965.EPI-14-1002
   PubMed Web of Science ®Google Scholar
• Yan J, Zhao X, Han S, et al. Evaluation of clinical plus imaging features and multidetector computed tomography texture analysis in preoperative risk grade prediction of small bowel gastrointestinal stromal tumors. J Comput Assist Tomogr. 2018;42(5):714–720. doi:10.1097/RCT.000000000000075630015796
   PubMed Web of Science ®Google Scholar